Institutional investors purchased a net $28.7 million shares of AZN during the quarter ended June 2015, and now own 8.41% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 14.4 Million shares of AstraZeneca
CAPITAL RESEARCH & MANAGEMENT CO... Bought 4.9 Million shares of AstraZeneca
CAMBIAR INVESTORS LLC Bought 4.2 Million shares of AstraZeneca